Founded in 2014, Varocto Inc. is an ophthalmic research and development company located in the City of Orange, California. Varocto is a spin-off of Alfred E. Mann Institute at USC. We are developing the next generation non-invasive retinal vascular screening machine utilizing OCT (Optical Coherence Tomography) and OCTA (Optical Coherence Tomographic Angiography). OCT angiography is a non-invasive new technology to image the three dimensional vasculature of the eye without requiring pupil dilation and without any injection of dye. For many eye diseases including diabetes and age-related macular degeneration, non-invasive screening for the occurrence of retinal vascular problems before vision has been damaged has the potential to improve overall eye health.
There is no investment information
No recent news or press coverage available for Varocto Inc.
We care about your data, and we'd love to use cookies make your experience better.